Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Cioccari

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|September 9, 2020
Cytokine and lipid metabolome effects of low-dose acetylsalicylic acid in critically ill patients with systemic inflammation: a pilot, feasibility, multicentre, randomised, placebo-controlled trialLuca Cioccari, Nora Luethi, Thy Duong, et al.
Critical Care Medicine|March 7, 2018
Liberal Glucose Control in ICU Patients With Diabetes: A Before-and-After StudyNora Luethi, Luca Cioccari, Peter Biesenbach, et al.
Intensive Care Medicine|October 22, 2018
Small volume resuscitation with 20% albumin in intensive care: physiological effects : The SWIPE randomised clinical trialJohan Mårtensson, Shailesh Bihari, Jonathan Bannard-Smith, et al.
JAMA|January 18, 2020
Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical TrialTomoko Fujii, Nora Luethi, Paul J Young, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|June 25, 2026
Renal replacement therapies and adherence to EXTRIP consensus criteria in lithium poisoning: the multicenter SILITOX studyÁlvaro Pineda-Torcuato, Antonio F Caballero-Bermejo, August Supervía, et al.
Acta Anaesthesiologica Scandinavica|August 12, 2020
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia (COVID STEROID) trial-Protocol and statistical analysis planMarie Warrer Petersen, Tine Sylvest Meyhoff, Marie Helleberg, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis planM W Munch, Anders Granholm, S N Myatra, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysisAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|November 10, 2021
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trialAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|April 1, 2022
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemiaAnders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|September 9, 2020
Cytokine and lipid metabolome effects of low-dose acetylsalicylic acid in critically ill patients with systemic inflammation: a pilot, feasibility, multicentre, randomised, placebo-controlled trialLuca Cioccari, Nora Luethi, Thy Duong, et al.
Critical Care Medicine|March 7, 2018
Liberal Glucose Control in ICU Patients With Diabetes: A Before-and-After StudyNora Luethi, Luca Cioccari, Peter Biesenbach, et al.
Intensive Care Medicine|October 22, 2018
Small volume resuscitation with 20% albumin in intensive care: physiological effects : The SWIPE randomised clinical trialJohan Mårtensson, Shailesh Bihari, Jonathan Bannard-Smith, et al.
JAMA|January 18, 2020
Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical TrialTomoko Fujii, Nora Luethi, Paul J Young, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|June 25, 2026
Renal replacement therapies and adherence to EXTRIP consensus criteria in lithium poisoning: the multicenter SILITOX studyÁlvaro Pineda-Torcuato, Antonio F Caballero-Bermejo, August Supervía, et al.
Acta Anaesthesiologica Scandinavica|August 12, 2020
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia (COVID STEROID) trial-Protocol and statistical analysis planMarie Warrer Petersen, Tine Sylvest Meyhoff, Marie Helleberg, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis planM W Munch, Anders Granholm, S N Myatra, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysisAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|November 10, 2021
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trialAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|April 1, 2022
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemiaAnders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, et al.
Pageof 7